Limited Methotrexate Recall Issued because of Possible Ethylene Glycol Contamination

A limited voluntary recall has been issued by Bedford Laboratories (Bedford) with respect to one lot of Methotrexate for Injection (Lot No. 859142 – Exp. 09/07) as a result of possible contamination with ethylene glycol, the active ingredient in anti-freeze.

Bedford, a division of Boehringer Ingelheim Pharmaceuticals Inc., is working with the FDA on this recall. The company has not received any reports of serious health or safety problems associated with the recalled lot of Methotrexate.

Patients who have questions about the product should contact their doctor. If, however, a patient has any vials of this one lot of Methotrexate for Injection have been instructed to discontinue distribution and use of this lot immediately and contact Bedford Laboratories Customer Service Department (1-800-562-4797) for a returned goods authorization.

Consumers that have questions regarding this recall should also contact the Bedford Customer Service Department at 1-800-562-4797, between the hours of 8 a.m. – 5 p.m. (EST).

The lot number in question was distributed throughout the United States in October and November 2005 to wholesalers and distributors, who further distribute the product to hospitals.

This entry was posted in Health Concerns. Bookmark the permalink.


Limited Methotrexate Recall Issued because of Possible Ethylene Glycol Contamination

A limited voluntary recall has been issued by Bedford Laboratories (Bedford) with respect to one lot of Methotrexate for Injection (Lot No. 859142 – Exp. 09/07) as a result of possible contamination with ethylene glycol, the active ingredient in anti-freeze.

Bedford, a division of Boehringer Ingelheim Pharmaceuticals Inc., is working with the FDA on this recall. The company has not received any reports of serious health or safety problems associated with the recalled lot of Methotrexate.

Patients who have questions about the product should contact their doctor. If, however, a patient has any vials of this one lot of Methotrexate for Injection have been instructed to discontinue distribution and use of this lot immediately and contact Bedford Laboratories Customer Service Department (1-800-562-4797) for a returned goods authorization.

Consumers that have questions regarding this recall should also contact the Bedford Customer Service Department at 1-800-562-4797, between the hours of 8 a.m. – 5 p.m. (EST).

The lot number in question was distributed throughout the United States in October and November 2005 to wholesalers and distributors, who further distribute the product to hospitals.

This entry was posted in Defective Products. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.